相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
Is COVID-19 receiving ADE from other coronaviruses?
Jason A. Tetro
MICROBES AND INFECTION (2020)
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
Renhong Yan et al.
SCIENCE (2020)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Bin Zhang et al.
CHEST (2020)
Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility
Jasper Fuk-Woo Chan et al.
CLINICAL INFECTIOUS DISEASES (2020)
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019
Juanjuan Zhao et al.
CLINICAL INFECTIOUS DISEASES (2020)
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Chenguang Shen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
The convalescent sera option for containing COVID-19
Arturo Casadevall et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Kai Duan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Against pandemic research exceptionalism
Alex John London et al.
SCIENCE (2020)
Development of an inactivated vaccine candidate for SARS-CoV-2
Qiang Gao et al.
SCIENCE (2020)
A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV
Meng Yuan et al.
SCIENCE (2020)
Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study
Shufa Zheng et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures
Kenrie P. Y. Hui et al.
LANCET RESPIRATORY MEDICINE (2020)
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2
Rui Shi et al.
NATURE (2020)
Human neutralizing antibodies elicited by SARS-CoV-2 infection
Bin Ju et al.
NATURE (2020)
Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins
Tommy Tsan-Yuk Lam et al.
NATURE (2020)
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
Yadi Zhou et al.
CELL DISCOVERY (2020)
Developing Covid-19 Vaccines at Pandemic Speed
Nicole Lurie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells
Yunlong Cao et al.
CELL (2020)
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19 A Randomized Clinical Trial
Ling Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Early safety indicators of COVID-19 convalescent plasma in 5000 patients
Michael J. Joyner et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Viral dynamics in mild and severe cases of COVID-19
Yang Liu et al.
LANCET INFECTIOUS DISEASES (2020)
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Takuya Sekine et al.
CELL (2020)
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Quan-Xin Long et al.
NATURE MEDICINE (2020)
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
Divij Mathew et al.
SCIENCE (2020)
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
Philip J. M. Brouwer et al.
SCIENCE (2020)
Use of Convalescent Plasma Therapy in Two COVID-19 Patients With Acute Respiratory Distress Syndrome in Korea
Jin Young Ahn et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2020)
A Highly Immunogenic, Protective, and Safe Adenovirus-Based Vaccine Expressing Middle East Respiratory Syndrome Coronavirus S1-CD40L Fusion Protein in a Transgenic Human Dipeptidyl Peptidase 4 Mouse Model
Anwar M. Hashem et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Antibody-dependent enhancement of influenza disease promoted by increase in hemagglutinin stem flexibility and virus fusion kinetics
Katie L. Winarski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Mind the Gap: How Interspecies Variability in IgG and Its Receptors May Complicate Comparisons of Human and Non-human Primate Effector Function
Andrew R. Crowley et al.
FRONTIERS IN IMMUNOLOGY (2019)
Fc-dependent functions are redundant to efficacy of anti-HIV antibody PGT121 in macaques
Matthew S. Parsons et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry
Yushun Wan et al.
JOURNAL OF VIROLOGY (2019)
Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection
Li Liu et al.
JCI INSIGHT (2019)
Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience
Jae-Hoon Ko et al.
ANTIVIRAL THERAPY (2018)
Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy
S. Sridhar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
A Tale of Two Viruses: Does Heterologous Flavivirus Immunity Enhance Zika Disease?
Carlos A. Sariol et al.
TRENDS IN MICROBIOLOGY (2018)
Evaluation of Antibody-Dependent Enhancement of SARS-CoV Infection in Rhesus Macaques Immunized with an Inactivated SARS-CoV Vaccine
Fan Luo et al.
VIROLOGICA SINICA (2018)
Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis
Lisa E. Gralinski et al.
MBIO (2018)
IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity
Taia T. Wang et al.
SCIENCE (2017)
Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection
David J. DiLillo et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Vaccines against respiratory syncytial virus: The time has finally come
Barney S. Graham
VACCINE (2016)
Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus
Anurodh Shankar Agrawal et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates
Qidi Wang et al.
ACS INFECTIOUS DISEASES (2016)
Influenza-Specific Antibody-Dependent Phagocytosis
Fernanda Ana-Sosa-Batiz et al.
PLOS ONE (2016)
The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis
John Mair-Jenkins et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Severe Acute Respiratory Syndrome-Associated Coronavirus Vaccines Formulated with Delta Inulin Adjuvants Provide Enhanced Protection while Ameliorating Lung Eosinophilic Immunopathology
Yoshikazu Honda-Okubo et al.
JOURNAL OF VIROLOGY (2015)
Active Replication of Middle East Respiratory Syndrome Coronavirus and Aberrant Induction of Inflammatory Cytokines and Chemokines in Human Macrophages: Implications for Pathogenesis
Jie Zhou et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy
Andrew Hiatt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Phagocytic cells contribute to the antibody-mediated elimination of pulmonary-infected SARS coronavirus
Fumihiko Yasui et al.
VIROLOGY (2014)
Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus
Ming Shum Yip et al.
VIROLOGY JOURNAL (2014)
Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus
Chien-Te Tseng et al.
PLOS ONE (2012)
Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH-and Cysteine Protease-Independent FcγR Pathway
Martial Jaume et al.
JOURNAL OF VIROLOGY (2011)
A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response
Meagan Bolles et al.
JOURNAL OF VIROLOGY (2011)
Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant
Larry Zeitlin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
Wanwisa Dejnirattisai et al.
SCIENCE (2010)
Prior Immunization with Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus (SARS-CoV) Nucleocapsid Protein Causes Severe Pneumonia in Mice Infected with SARS-CoV
Fumihiko Yasui et al.
JOURNAL OF IMMUNOLOGY (2008)
Fc receptor but not complement binding is important in antibody protection against HIV
Ann J. Hessell et al.
NATURE (2007)
Atypical measles and enhanced respiratory syncytial virus disease (ERD) made simple
Fernando P. Polack
PEDIATRIC RESEARCH (2007)
Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcγRII- dependent entry into B cells in vitro
Yin Wing Kam et al.
VACCINE (2007)
Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants
Damon Deming et al.
PLOS MEDICINE (2006)
Immunogenicity and protective efficacy in monkeys of purified inactivated Vero-cell SARS vaccine
E Qin et al.
VACCINE (2006)
Neutralizing antibody response and SARS severity
MS Ho et al.
EMERGING INFECTIOUS DISEASES (2005)
Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis
CY Cheung et al.
JOURNAL OF VIROLOGY (2005)
Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets
M Czub et al.
VACCINE (2005)
Use of convalescent plasma therapy in SARS patients in Hong Kong
Y Cheng et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)
Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice
H Bisht et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice
ZY Yang et al.
NATURE (2004)
Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS
A Bukreyev et al.
LANCET (2004)
Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets
H Weingartl et al.
JOURNAL OF VIROLOGY (2004)
A role for nonprotective complement-fixing antibodies with low avidity for measles virus in atypical measles
FP Polack et al.
NATURE MEDICINE (2003)
Antibody-dependent enhancement of Ebola virus infection
A Takada et al.
JOURNAL OF VIROLOGY (2003)
A role for immune complexes in enhanced respiratory syncytial virus disease
FP Polack et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Infectivity-enhancing antibodies to ebola virus glycoprotein
A Takada et al.
JOURNAL OF VIROLOGY (2001)
分享论文
